Armstrong set to launch robot to guide deep-brain procedures
This article was originally published in Clinica
Medical robotic company Armstrong Healthcare plans to attach the CE mark to its Pathfinder precision localiser for image-guided neurosurgery in February. Armstrong will launch the product in major European countries soon afterwards and expects to receive FDA approval in mid-2000.
You may also be interested in...
Stephen Hahn’s low visibility period as the newly installed FDA commissioner comes to an abrupt end. Trump offers generous praise amid COVID-19 response – but how quickly might that change to blame?
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.